A Study of LY2140023 in Hepatically-Impaired Participants
NCT01475136
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Insufficiency
Interventions
DRUG:
LY2140023
Sponsor
Denovo Biopharma LLC